News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,413 Results
Type
Article (14236)
Company Profile (109)
Press Release (295068)
Section
Business (99323)
Career Advice (570)
Deals (20504)
Drug Delivery (66)
Drug Development (39954)
Employer Resources (49)
FDA (6990)
Job Trends (7168)
News (171084)
Policy (15524)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (505)
Adcomms (6)
Allergies (30)
Alliances (26440)
ALS (40)
Alzheimer's disease (470)
Antibody-drug conjugate (ADC) (36)
Approvals (7023)
Artificial intelligence (100)
Autoimmune disease (5)
Automation (3)
Bankruptcy (188)
Best Places to Work (5269)
BIOSECURE Act (9)
Biosimilars (53)
Biotechnology (46)
Bladder cancer (18)
Brain cancer (15)
Breast cancer (86)
Cancer (660)
Cardiovascular disease (63)
Career advice (498)
Career pathing (10)
CAR-T (21)
Cell therapy (93)
Cervical cancer (4)
Clinical research (33568)
Collaboration (327)
Compensation (140)
Complete response letters (16)
COVID-19 (808)
CRISPR (18)
C-suite (105)
Cystic fibrosis (41)
Data (672)
Denatured (15)
Depression (12)
Diabetes (86)
Diagnostics (1889)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (55)
Drug pricing (64)
Drug shortages (12)
Duchenne muscular dystrophy (27)
Earnings (36158)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (43964)
Executive appointments (366)
FDA (7403)
Featured Employer (22)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (238)
Gene editing (36)
Generative AI (8)
Gene therapy (100)
GLP-1 (340)
Government (1402)
Grass and pollen (2)
Guidances (17)
Healthcare (5069)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (28)
Indications (12)
Infectious disease (846)
Inflammatory bowel disease (63)
Inflation Reduction Act (6)
Influenza (15)
Intellectual property (41)
Interviews (77)
IPO (9187)
IRA (29)
Job creations (2149)
Job search strategy (447)
Kidney cancer (6)
Labor market (8)
Layoffs (176)
Leadership (3)
Legal (3948)
Liver cancer (19)
Lung cancer (93)
Lymphoma (54)
Machine learning (1)
Management (16)
Manufacturing (141)
MASH (31)
Medical device (2929)
Medtech (2931)
Mergers & acquisitions (11643)
Metabolic disorders (251)
Multiple sclerosis (18)
NASH (14)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (647)
NextGen: Class of 2025 (2219)
Non-profit (723)
Northern California (782)
Now hiring (7)
Obesity (138)
Opinion (118)
Ovarian cancer (21)
Pain (52)
Pancreatic cancer (27)
Parkinson's disease (49)
Partnered (8)
Patents (109)
Patient recruitment (31)
Peanut (10)
People (31725)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (9032)
Phase II (14428)
Phase III (12393)
Pipeline (378)
Podcasts (44)
Policy (57)
Postmarket research (1427)
Preclinical (3615)
Press Release (26)
Prostate cancer (45)
Psychedelics (8)
Radiopharmaceuticals (137)
Rare diseases (165)
Real estate (2942)
Recruiting (17)
Regulatory (10990)
Reports (15)
Research institute (650)
Resumes & cover letters (67)
Rett syndrome (1)
RNA editing (1)
RSV (8)
Schizophrenia (36)
Series A (36)
Series B (16)
Service/supplier (3)
Sickle cell disease (35)
Southern California (833)
Special edition (6)
Sponsored (6)
Startups (1884)
State (2)
Stomach cancer (3)
Supply chain (30)
The Weekly (28)
United States (8263)
Vaccines (161)
Venture capitalists (13)
Webinars (10)
Weight loss (91)
Women's health (8)
Worklife (3)
Date
Today (25)
Last 7 days (268)
Last 30 days (1288)
Last 365 days (14859)
2025 (2907)
2024 (15348)
2023 (17676)
2022 (23558)
2021 (24856)
2020 (23765)
2019 (18185)
2018 (14264)
2017 (16086)
2016 (14953)
2015 (18006)
2014 (14142)
2013 (11993)
2012 (12940)
2011 (13195)
2010 (12114)
Location
Africa (317)
Alabama (15)
Alaska (1)
Arizona (69)
Arkansas (3)
Asia (22020)
Australia (2871)
California (1973)
Canada (922)
China (221)
Colorado (74)
Connecticut (97)
Delaware (59)
Europe (41863)
Florida (372)
Georgia (48)
Idaho (14)
Illinois (199)
India (13)
Indiana (141)
Iowa (1)
Japan (84)
Kansas (59)
Kentucky (13)
Maine (35)
Maryland (290)
Massachusetts (1584)
Michigan (83)
Minnesota (105)
Mississippi (2)
Missouri (24)
Montana (10)
Nebraska (8)
Nevada (29)
New Hampshire (10)
New Jersey (792)
New Mexico (8)
New York (634)
North Carolina (497)
North Dakota (2)
Northern California (782)
Ohio (58)
Oklahoma (4)
Oregon (18)
Pennsylvania (491)
Puerto Rico (6)
Rhode Island (9)
South America (532)
South Carolina (7)
Southern California (833)
Tennessee (40)
Texas (293)
Utah (62)
Virginia (71)
Washington D.C. (29)
Washington State (143)
West Virginia (1)
Wisconsin (20)
309,413 Results for "vyera pharmaceuticals llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase Agreement to Sell Rights to Daraprim and Vecamyl
Vyera Pharmaceuticals, LLC and Phoenixus AG announced that they have entered into an Asset Purchase Agreement related to Daraprim and Vecamyl.
August 1, 2023
·
4 min read
Pharm Country
Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals
Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera Pharmaceuticals.
December 7, 2023
·
1 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Press Releases
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
February 26, 2025
·
2 min read
Press Releases
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
February 24, 2025
·
6 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
Press Releases
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
March 6, 2025
·
5 min read
1 of 30,942
Next
